Active	Status	Sponsor type	Region	Phase	Filter
5 Active 9 Inactive 14 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
pegsiticase/SVP-rapamycin (SEL212) / SOBI, Cartesian Therap
DISSOLVE I, NCT04513366: A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy	Completed	3	112	US	SEL-212 low-dose, SEL-212 high-dose, Normal Saline	Swedish Orphan Biovitrum	Chronic Gout	07/22	12/22
DISSOLVE II, NCT04596540: A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II	Completed	3	153	US, RoW	SEL-212 low-dose, SEL-212 high-dose, Placebo	Swedish Orphan Biovitrum	Chronic Gout	01/23	01/23
pegsiticase (SEL-037) / Cartesian Therap
NCT04047394: A Study to Determine the Safety, Tolerability, PK and Preliminary PD of SSS11 in Chinese Healthy Adult Volunteers	Recruiting	1	33	RoW	PEGylated recombinant candida urate oxidase, SSS11	Shenyang Sunshine Pharmaceutical Co., LTD.	Gout	10/22	12/22
NCT06629376: Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia	Recruiting	1	60	RoW	Pegylated Recombinant Candida Utilis Uricase for Injection, SSS11	Shenyang Sunshine Pharmaceutical Co., LTD.	Gout, Hyperuricemia	04/25	08/25
SEL-110 / Cartesian Therap
reiMMAgine, NCT05778877: A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SEL-302 in Pediatric Subjects With MMA	Withdrawn	1/2	6	US	SEL-302, AAV8-MMUT	Selecta Biosciences, Inc., National Human Genome Research Institute (NHGRI)	Methylmalonic Acidemia (MMA)	08/25	08/29
SVP-enabled peanut allergy therapeutic vaccine / Cartesian Therap
No trials found
IgA protease / IGAN BioSci, Cartesian Therap
No trials found